Riskpilot← Back to searchSign inGet full accessNephroCare Sverige AB
ABActiveOrg 5567610372Frans Malmrosgatan 24General medical practice activities · NACE 8621Est. 200810-19 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 0
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 0 | — |
| Total assets | SEK 6,1M | +0% |
| Equity | SEK 6,1M | +0% |
| Employees | — | — |
Legal name
NephroCare Sverige AB
Org number
5567610372
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 juli 2008
Share capital
SEK 100 000
Employees
10-19
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva dialysvårdsverksamhet vid sjukhus och i hemmiljö och äga, förhyra och förvalta lokaler samt därmed förenlig verksamhet.
Address
Frans Malmrosgatan 24
Phone
+46859477600
Email
anette.parkeryd@freseniusmedicalcare.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | 0 | 0 | 0 |
| Net financials | — | — | — | — | — |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 100 | 6 100 | 6 100 | 6 100 | 6 100 |
| Equity | 6 100 | 6 100 | 6 100 | 6 100 | 6 100 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 |
| Total debt | — | — | — | — | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SJ Chief Executive Officer | Chief Executive Officer | 2020 |
AH Chief Auditor | Chief Auditor | 2020 |
| Former (1) | ||
RB Chief Auditor | Chief Auditor | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FRESENIUS MEDICAL CARE BETEILIGUNGSGESELLSCHAFTFresenius Medical Care Sverige AB
NephroCare Sverige AB (this company)Board members of NephroCare Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Johan Fredrik Gustafsson | Chief Executive Officer | 0 companies |
| Anna Hélène Maria Westberg | Chief Auditor | 0 companies |
| Ragnhild Birgitta Johansson Vognsen | Chief Auditor | 0 companies |
| Gert Grauer | Board of Directors | 0 companies |
| Gunther Klotz | Chairman | 0 companies |
| Anette Solveig Borgman Parkeryd | Deputy Board Member | 0 companies |